Copyright © 2012 Yasuteru Kondo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. M. J. Alter, D. Kruszon-Moran, O. V. Nainan et al., “The prevalence of hepatitis C virus infection in the United States, 1988 through 1994,” The New England Journal of Medicine, vol. 341, no. 8, pp. 556–562, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
2. S. S. Chuang, Y. L. Liao, S. T. Chang et al., “Hepatitis C virus infection is significantly associated with malignant lymphoma in Taiwan, particularly with nodal and splenic marginal zone lymphomas,” Journal of Clinical Pathology, vol. 63, no. 7, pp. 595–598, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
3. F. Lunel and L. Musset, “Mixed cryoglobulinemia and hepatitis C virus infection,” Minerva Medica, vol. 92, no. 1, pp. 35–42, 2001. View at Scopus
4. T. Mizutani, N. Kato, M. Hirota, K. Sugiyama, A. Murakami, and K. Shimotohno, “Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells,” Biochemical and Biophysical Research Communications, vol. 212, no. 3, pp. 906–911, 1995. View at Publisher · View at Google Scholar · View at PubMed
5. T. Mizutani, N. Kato, S. Saito, M. Ikeda, K. Sugiyama, and K. Shimotohno, “Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2,” Journal of Virology, vol. 70, no. 10, pp. 7219–7223, 1996. View at Scopus
6. N. Nakajima, M. Hijikata, H. Yoshikura, and Y. K. Shimizu, “Characterization of long-term cultures of hepatitis C virus,” Journal of Virology, vol. 70, no. 5, pp. 3325–3329, 1996. View at Scopus
7. E. Nissen, M. Hohne, and E. Schreier, “In vitro replication of hepatitis C virus in a human lymphoid cell line (H9),” Journal of Hepatology, vol. 20, no. 3, p. 437, 1994. View at Scopus
8. Y. K. Shimizu, S. M. Feinstone, M. Kohara, R. H. Purcell, and H. Yoshikura, “Hepatitis C virus: detection of intracellular virus particles by electron microscopy,” Hepatology, vol. 23, no. 2, pp. 205–209, 1996. View at Publisher · View at Google Scholar · View at Scopus
9. Y. K. Shimizu, H. Igarashi, T. Kanematu et al., “Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees,” Journal of Virology, vol. 71, no. 8, pp. 5769–5773, 1997. View at Scopus
10. Y. K. Shimizu, A. Iwamoto, M. Hijikata, R. H. Purcell, and H. Yoshikura, “Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 12, pp. 5477–5481, 1992. View at Publisher · View at Google Scholar · View at Scopus
11. Y. K. Shimizu, R. H. Purcell, and H. Yoshikura, “Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 13, pp. 6037–6041, 1993. View at Scopus
12. Y. K. Shimizu and H. Yoshikura, “Multicycle infection of hepatitis C virus in cell culture and inhibition by alpha and beta interferons,” Journal of Virology, vol. 68, no. 12, pp. 8406–8408, 1994. View at Scopus
13. Y. Kondo, Y. Ueno, E. Kakazu et al., “Lymphotropic HCV strain can infect human primary naïve CD4+ cells and affect their proliferation and IFN-γ secretion activity,” Journal of Gastroenterology, vol. 46, no. 2, pp. 232–241, 2011. View at Publisher · View at Google Scholar · View at PubMed
14. M. Ito, A. Masumi, K. Mochida et al., “Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection,” Journal of Innate Immunity, vol. 2, no. 6, pp. 607–617, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
15. T. N. Q. Pham and T. I. Michalak, “Occult persistence and lymphotropism of hepatitis C virus infection,” World Journal of Gastroenterology, vol. 14, no. 18, pp. 2789–2793, 2008. View at Publisher · View at Google Scholar · View at Scopus
16. A. L. Zignego, C. Giannini, M. Monti, and L. Gragnani, “Hepatitis C virus lymphotropism: lessons from a decade of studies,” Digestive and Liver Disease, vol. 39, no. 1, pp. S38–S45, 2007. View at Publisher · View at Google Scholar · View at Scopus
17. T. I. Michalak, “Immune cell reservoirs of persisting hepatitis C virus,” Gut, vol. 59, no. 7, supplement, pp. 867–868, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
18. S. J. Karavattathayyil, G. Kalkeri, H. J. Liu et al., “Detection of hepatitis C virus RNA sequences in B-cell non-Hodgkin lymphoma,” American Journal of Clinical Pathology, vol. 113, no. 3, pp. 391–398, 2000. View at Scopus
19. M. Luppi, M. G. Ferrari, G. Bonaccorsi et al., “Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia,” Leukemia, vol. 10, no. 2, pp. 351–355, 1996. View at Scopus
20. K. Machida, K. T.-H. Cheng, C. K. Lai, K. S. Jeng, V. M.-H. Sung, and M. M.C. Lai, “Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STATS activation,” Journal of Virology, vol. 80, no. 14, pp. 7199–7207, 2006. View at Publisher · View at Google Scholar · View at PubMed
21. K. Machida, K. T. H. Cheng, V. M. H. Sung, A. M. Levine, S. Foung, and M. M. C. Lai, “Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6,” Journal of Virology, vol. 80, no. 2, pp. 866–874, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
22. G. J. Roboz, “Hepatitis C and B-cell lymphoma,” AIDS Patient Care and STDs, vol. 12, no. 8, pp. 605–609, 1998. View at Scopus
23. M. H. V. Sung, S. Shimodaira, A. L. Doughty et al., “Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection,” Journal of Virology, vol. 77, no. 3, pp. 2134–2146, 2003. View at Publisher · View at Google Scholar · View at Scopus
24. A. Bergqvist and C. M. Rice, “Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein,” Journal of Virology, vol. 75, no. 2, pp. 772–781, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
25. A. Bergqvist, S. Sundström, L. Y. Dimberg, E. Gylfe, and M. G. Masucci, “The hepatitis C virus core protein modulates T cell responses by inducing spontaneous and altering T-cell receptor-triggered Ca²⁺ oscillations,” The Journal of Biological Chemistry, vol. 278, no. 21, pp. 18877–18883, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
26. M. Domínguez-Villar, A. Muñoz-Suano, B. Anaya-Baz et al., “Hepatitis C virus core protein up-regulates anergy-related genes and a new set of genes, which affects T cell homeostasis,” Journal of Leukocyte Biology, vol. 82, no. 5, pp. 1301–1310, 2007. View at Publisher · View at Google Scholar · View at PubMed
27. Y. Kondo, K. Machida, H. M. Liu et al., “Hepatitis C virus infection of T cells inhibits proliferation and enhances Fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6,” Journal of Infectious Diseases, vol. 199, no. 5, pp. 726–736, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
28. Y. Kondo, V. M. H. Sung, K. Machida, M. Liu, and M. M. C. Lai, “Hepatitis C virus infects T cells and affects interferon-γ signaling in T cell lines,” Virology, vol. 361, no. 1, pp. 161–173, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
29. K. Machida, K. T. H. Cheng, V. M. H. Sung, K. J. Lee, A. M. Levine, and M. M. C. Lai, “Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes,” Journal of Virology, vol. 78, no. 16, pp. 8835–8843, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
30. K. Machida, K. T. N. Cheng, V. M. H. Sung et al., “Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 12, pp. 4262–4267, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
31. Y. Hu, A. Shahidi, S. Park, D. Guilfoyle, and I. Hirshfield, “Detection of extrahepatic hepatitis C virus replication by a novel, highly sensitive, single-tube nested polymerase chain reaction,” American Journal of Clinical Pathology, vol. 119, no. 1, pp. 95–100, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
32. N. Kato, M. Ikeda, K. Sugiyama, T. Mizutani, T. Tanaka, and K. Shimotohno, “Hepatitis C virus population dynamics in human lymphocytes and hepatocytes infected in vitro,” Journal of General Virology, vol. 79, no. 8, pp. 1859–1869, 1998. View at Scopus
33. N. Kato, T. Nakazawa, T. Mizutani, and K. Shimotohno, “Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection,” Biochemical and Biophysical Research Communications, vol. 206, no. 3, pp. 863–869, 1995. View at Publisher · View at Google Scholar · View at PubMed
34. S. A. MacParland, T. N. O. Pham, S. A. Gujar, and T. I. Michalak, “De novo infection and propagation of wild-type Hepatitis C virus in human T lymphocytes in vitro,” Journal of General Virology, vol. 87, no. 12, pp. 3577–3586, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
35. Y. Sugawara, M. Makuuchi, N. Kato, K. Shimotohno, and K. Takada, “Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1,” EMBO Journal, vol. 18, no. 20, pp. 5755–5760, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
36. P. Baré, I. Massud, C. Parodi et al., “Continuous release of hepatitis C virus (HCV) by peripheral blood mononuclear cells and B-lymphoblastoid cell-line cultures derived from HCV-infected patients,” Journal of General Virology, vol. 86, no. 6, pp. 1717–1727, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
37. T. N. Q. Pham, D. King, S. A. MacParland et al., “Hepatitis C Virus Replicates in the Same Immune Cell Subsets in Chronic Hepatitis C and Occult Infection,” Gastroenterology, vol. 134, no. 3, pp. 812–822, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
38. I. Rasul, F. A. Shepherd, S. Kamel-Reid, M. Krajden, D. Pantalony, and E. Jenny Heathcote, “Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia,” Hepatology, vol. 29, no. 2, pp. 543–547, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
39. S. Marukian, C. T. Jones, L. Andrus et al., “Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells,” Hepatology, vol. 48, no. 6, pp. 1843–1850, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
40. R. E. Lanford, D. Chavez, F. V. Chisari, and C. Sureau, “Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand- specific rTth reverse transcriptase PCR,” Journal of Virology, vol. 69, no. 12, pp. 8079–8083, 1995. View at Scopus
41. P. H. McGuinness, G. A. Bishop, G. W. McCaughan, R. Trowbridge, and E. J. Gowans, “False detection of negative-strand hepatitis C virus RNA,” The Lancet, vol. 343, no. 8896, pp. 551–552, 1994. View at Publisher · View at Google Scholar · View at Scopus
42. L. Muratori, D. Gibellini, M. Lenzi et al., “Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction,” Blood, vol. 88, no. 7, pp. 2768–2774, 1996. View at Scopus
43. S. De Vita, D. Sansonno, R. Dolcetti et al., “Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia,” Blood, vol. 86, no. 5, pp. 1887–1892, 1995. View at Scopus
44. T. N. Q. Pham, S. A. MacParland, C. S. Coffin, S. S. Lee, F. R. Bursey, and T. I. Michalak, “Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells,” Journal of General Virology, vol. 86, no. 3, pp. 657–666, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
45. K. Machida, Y. Kondo, J. Y. Huang et al., “Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein,” Journal of Virology, vol. 82, no. 13, pp. 6711–6720, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
46. K. Machida, K. T. H. Cheng, N. Pavio, V. M. H. Sung, and M. M. C. Lai, “Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells,” Journal of Virology, vol. 79, no. 13, pp. 8079–8089, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
47. Y. Kasama, S. Sekiguchi, M. Saito et al., “Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo,” Blood, vol. 116, no. 23, pp. 4926–4933, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
48. A. Craxì, G. Laffi, and A. L. Zignego, “Hepatitis C virus (HCV) infection: a systemic disease,” Molecular Aspects of Medicine, vol. 29, no. 1-2, pp. 85–95, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
49. M. P. Simula, L. Caggiari, A. Gloghini, and V. De Re, “HCV-related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens,” Annals of the New York Academy of Sciences, vol. 1110, pp. 121–130, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
50. D. Sansonno, F. A. Tucci, G. Lauletta et al., “Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinaemia,” Clinical and Experimental Immunology, vol. 147, no. 2, pp. 241–248, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
51. T. Mizuochi, M. Ito, K. Takai, and K. Yamaguchi, “Peripheral blood memory B cells are resistant to apoptosis in chronic hepatitis C patients,” Virus Research, vol. 155, no. 1, pp. 349–351, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
52. T. Laskus, M. Radkowski, L. F. Wang, H. Vargas, and J. Rakela, “The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1,” Journal of Infectious Diseases, vol. 178, no. 4, pp. 1189–1192, 1998. View at Scopus
53. D. L. Thomas, J. W. Shih, H. J. Alter et al., “Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users,” Journal of Infectious Diseases, vol. 174, no. 4, pp. 690–695, 1996. View at Scopus
54. Y. Li, X. Wang, S. D. Douglas et al., “CD8+ T cell depletion amplifies hepatitis C virus replication in peripheral blood mononuclear cells,” Journal of Infectious Diseases, vol. 192, no. 6, pp. 1093–1101, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
55. S. Z. Salahuddin, K. A. Snyder, A. Godwin et al., “The simultaneous presence and expression of human hepatitis C virus (HCV), human herpesvirus-6 (HHV-6), and human immunodeficiency virus-1 (HIV-1) in a single human T-cell,” Virology Journal, vol. 4, article 106, 2007. View at Publisher · View at Google Scholar · View at PubMed
56. M. Radkowski, L. F. U. Wang, H. E. Vargas, J. Rakela, and T. Laskus, “Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation,” Transplantation, vol. 66, no. 5, pp. 664–666, 1998. View at Publisher · View at Google Scholar · View at Scopus
57. G. Coquillard and B. K. Patterson, “Determination of hepatitis C virus-infected, monocyte lineage reservoirs in individuals with or without HIV coinfection,” Journal of Infectious Diseases, vol. 200, no. 6, pp. 947–954, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
58. T. Laskus, M. Radkowski, A. Piasek et al., “Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes,” Journal of Infectious Diseases, vol. 181, no. 2, pp. 442–448, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
59. T. Kanto, N. Hayashi, T. Takehara et al., “Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals,” Journal of Immunology, vol. 162, no. 9, pp. 5584–5591, 1999. View at Scopus
60. C. Bain, A. Fatmi, F. Zoulim, J. P. Zarski, C. Trépo, and G. Inchauspé, “Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection,” Gastroenterology, vol. 120, no. 2, pp. 512–524, 2001. View at Scopus
61. S. Agaugué, L. Perrin-Cocon, P. André, and V. Lotteau, “Hepatitis C lipo-viro-particle from chronically infected patients interferes with TLR4 signaling in dendritic cell,” PLoS ONE, vol. 2, no. 3, article e330, 2007. View at Publisher · View at Google Scholar · View at PubMed
62. E. Tsubouchi, S. M. F. Akbar, N. Horiike, and M. Onji, “Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection,” Journal of Gastroenterology, vol. 39, no. 8, pp. 754–762, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
63. M. C. Navas, A. Fuchs, E. Schvoerer, A. Bohbot, A. M. Aubertin, and F. Stoll-Keller, “Dendritic cell susceptibility to hepatitis C virus genotype 1 infection,” Journal of Medical Virology, vol. 67, no. 2, pp. 152–161, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
64. N. Goutagny, A. Fatmi, V. De Ledinghen et al., “Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection,” Journal of Infectious Diseases, vol. 187, no. 12, pp. 1951–1958, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
65. I. Pachiadakis, G. Pollara, B. M. Chain, and N. V. Naoumov, “Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?” The Lancet Infectious Diseases, vol. 5, no. 5, pp. 296–304, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
66. V. Falcón, N. Acosta-Rivero, M. Shibayama et al., “HCV core protein localizes in the nuclei of nonparenchymal liver cells from chronically HCV-infected patients,” Biochemical and Biophysical Research Communications, vol. 329, no. 4, pp. 1320–1328, 2005. View at Publisher · View at Google Scholar · View at PubMed
67. N. Watanabe, H. Aizaki, T. Matsuura, S. Kojima, T. Wakita, and T. Suzuki, “Hepatitis C virus RNA replication in human stellate cells regulates gene expression of extracellular matrix-related molecules,” Biochemical and Biophysical Research Communications, vol. 407, no. 1, pp. 135–140, 2011. View at Publisher · View at Google Scholar · View at PubMed
68. D. Sansonno, C. Lotesoriere, V. Cornacchiulo et al., “Hepatitis C virus infection involves CD34+ hematopoietic progenitor cells in hepatitis C virus chronic carriers,” Blood, vol. 92, no. 9, pp. 3328–3337, 1998. View at Scopus
69. D. Sansonno, A. R. Iacobelli, V. Cornacchiulo, G. Iodice, and F. Dammacco, “Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients,” Clinical and Experimental Immunology, vol. 103, no. 3, pp. 414–421, 1996. View at Scopus
70. J. F. Tomás, E. Rodriguez-Iñigo, J. Bartolomé, A. Alegre, J. M. Fernández-Rañada, and V. Carreño, “Transplantation of allogeneic CD34-selected peripheral stem cells does not prevent transmission of hepatitis C virus from an infected donor,” Bone Marrow Transplantation, vol. 24, no. 1, pp. 109–112, 1999. View at Scopus